These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25561485)

  • 1. Making a medicine out of MDMA.
    Sessa B; Nutt D
    Br J Psychiatry; 2015 Jan; 206(1):4-6. PubMed ID: 25561485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics".
    Sessa B
    Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy (MDMA) dependence.
    Jansen KL
    Drug Alcohol Depend; 1999 Jan; 53(2):121-4. PubMed ID: 10080038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.
    Sessa B
    Neurotherapeutics; 2017 Jul; 14(3):741-749. PubMed ID: 28477247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale.
    Johansen PØ; Krebs TS
    J Psychopharmacol; 2009 Jun; 23(4):389-91. PubMed ID: 19273493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic investigation with MDMA (ecstasy)].
    Bouso Saiz JC; Gómez-Jarabo G
    Med Clin (Barc); 2003 Sep; 121(8):318; author reply 318-9. PubMed ID: 14499096
    [No Abstract]   [Full Text] [Related]  

  • 10. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.
    Schenk S; Newcombe D
    J Clin Psychopharmacol; 2018 Dec; 38(6):632-638. PubMed ID: 30303861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Martin SF; Yazar-Klosinski B; Michel Y; Brewerton TD; Doblin R
    J Psychopharmacol; 2013 Jan; 27(1):28-39. PubMed ID: 23172889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.
    Amoroso T; Workman M
    J Psychopharmacol; 2016 Jul; 30(7):595-600. PubMed ID: 27118529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psilocybin and MDMA for the treatment of trauma-related psychopathology.
    Bird CIV; Modlin NL; Rucker JJH
    Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of psychedelic agents.
    Pathania R
    Br J Psychiatry; 2015 May; 206(5):433. PubMed ID: 25934305
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychedelic drugs-a new era in
psychiatry?
.
    Nutt D
    Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Psychiatric Uses for MDMA.
    Yazar-Klosinski BB; Mithoefer MC
    Clin Pharmacol Ther; 2017 Feb; 101(2):194-196. PubMed ID: 27859039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
    Smith KW; Sicignano DJ; Hernandez AV; White CM
    J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.
    Bedi G; Cotton SM; Guerin AA; Jackson HJ
    Aust N Z J Psychiatry; 2023 Apr; 57(4):476-481. PubMed ID: 36165006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.